Related Experiment Video
Updated: Aug 9, 2026
Forward Genetic Approaches in Chlamydia trachomatis
Published on: October 24, 2013
Workshop on in vitro neutralization of Chlamydia trachomatis: summary of proceedings
G I Byrne1, R S Stephens, G Ada
1Dept. of Medical Microbiology, University of Wisconsin, Madison 53706.
Insights
This study assessed an in vitro assay for neutralizing antibodies against Chlamydia trachomatis. The assay showed that antibodies targeting specific outer membrane protein epitopes can neutralize the bacteria, aiding vaccine development.
Area of Science:
- Immunology
- Microbiology
- Vaccine Development
Background:
- Assessing functional antibody responses to Chlamydia trachomatis is crucial for understanding immunity and developing vaccines.
- Current methods may not fully capture the protective capacity of antibodies against Chlamydia.
Purpose of the Study:
- To evaluate an in vitro antibody-mediated neutralization assay for its effectiveness in measuring functional antibody responses to Chlamydia trachomatis.
- To determine the utility of this assay in identifying potential vaccine candidates and correlates of protection.
Main Methods:
- An in vitro neutralization assay was developed and tested using monoclonal antibodies against Chlamydia trachomatis serovar B.
- Antibodies targeting major outer membrane protein (MOMP) epitopes and chlamydial lipopolysaccharide were used to assess neutralizing activity.
Main Results:
- Monoclonal antibodies targeting specific MOMP epitopes demonstrated significant in vitro neutralizing activity (up to 90%).
- Theoretical calculations suggest 100% neutralization is achievable with antibody binding to 10% of MOMP molecules.
- Antibodies against heterologous MOMP or chlamydial lipopolysaccharide showed no neutralizing activity.
Conclusions:
- The standardized in vitro neutralization assay is a valuable tool for assessing functional antibody responses to Chlamydia trachomatis.
- This assay can help determine if in vitro neutralizing antibodies predict protective immunity and identify promising vaccine targets.
Abstract:
A task force evaluated an in vitro antibody-mediated chlamydial neutralization assay for its utility as a method to assess functional correlates of antibody responses to Chlamydia trachomatis. Two monoclonal antibodies that recognize different major outer membrane protein (MOMP) epitopes for a C. trachomatis serovar B strain exhibit good in vitro neutralizing activity, with a maximum of 90% neutralization. Calculations based on the 50% neutralization point indicated that 100% neutralization could theoretically be achieved when only 10% of the MOMP molecules bound antibody. Monoclonal antibodies that recognized either a heterologous MOMP or the genus-specific chlamydial lipopolysaccharide did not produce neutralizing activity. The standardized assay will be useful to establish if in vitro neutralizing antibody responses are predictive of protective immunity and will aid in defining chlamydial antigens and epitopes that may be attractive vaccine candidates.
Related Concept Videos
01:40Cell-mediated Immune Responses
01:18Trichomoniasis